Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.

"Disclosure Shoko Akiyama, Masao Yarita, Kenichi Hashimoto, Kieran J Rothnie, and Afisi S Ismaila are employees of, and/or hold stocks/shares in, GSK. Alexandrosz Czira and Takeo Ishii were employees of GSK at the time of the study. Robert P Wood, Lucinda J Camidge, Hannah Wallis, Thomas Jennison, and Rosie AC Wild are employees of Adelphi Real World. Adelphi Real World received funding from GSK to conduct the study only. The authors report no other conflicts of interest in this work."

"This study was funded by GSK (study number 217636). GSK-affiliated authors were involved in study conception and design, data analysis, data interpretation, and the decision to submit the article for publication. GSK funded the article processing charges and open access fee."